Lecicarbon E Co2-Laxans

Sodium Hydrogen Carbonate and Sodium Dihydrogen Phosphate, the active ingredient in Lecicarbon E Co2-Laxans, is an osmotic laxative presented as a rectal solution/enema for rectal use. It relieves constipation by drawing water into the bowel lumen, facilitating evacuation in adults. GNH USA supplies Lecicarbon E Co2-Laxans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lecicarbon E Co2-Laxans acts as an osmotic laxative to treat functional bowel disorders characterized by reduced stool passage. - Constipation: facilitates bowel evacuation by increasing intraluminal water content, softening stool and promoting peristalsis.

Lecicarbon E Co2-Laxans may cause a range of adverse reactions.

Common Side Effects: - Abdominal cramping: mild to moderate discomfort in the lower abdomen. - Flatulence: increased gas production after administration. - Rectal irritation: burning or itching at the site of application. - Nausea: transient feeling of queasiness. - Electrolyte imbalance (mild): temporary changes in sodium or phosphate levels.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss requiring medical attention. - Electrolyte disturbances (severe): significant shifts in sodium or phosphate that may affect cardiac or neurological function. - Rectal bleeding: unexpected bleeding from the rectal mucosa. - Allergic reaction: rash, swelling, or difficulty breathing.

Before using Lecicarbon E Co2-Laxans, consider the following safety measures. - Assess hydration status: ensure the patient is not severely dehydrated. - Avoid in intestinal obstruction: contraindicated if a mechanical blockage is present. - Use cautiously with electrolyte disorders: monitor serum levels if the patient has known imbalances. - Do not exceed recommended volume: follow prescriber instructions for the amount administered. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lecicarbon E Co2-Laxans can interact with other medicines that affect fluid or electrolyte balance.

Major Interactions (Avoid): - Concurrent osmotic laxatives: may cause severe electrolyte disturbances. - Mineral oil: increased risk of aspiration if both are used together.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance fluid loss, requiring electrolyte monitoring. - Anticholinergic agents: may reduce the laxative effect, potentially requiring dose adjustment. - Antacids containing sodium: could add to sodium load, necessitating periodic lab checks.